BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

PsychoGenics Inc. 

765 Old Saw Mill River Road

Tarrytown  New York  10591  U.S.A.
Phone: 914-406-8000 Fax: 914-593-0645


SEARCH JOBS

PsychoGenics is a contract research organization (CRO) with focus on CNS disorders that offers a wide range of standard and customized preclinical services. PsychoGenics provides a full complement of partnered drug discovery capabilities with a focus on psychiatric, cognitive and neurodegenerative disorders, pain, inflammation, spinal cord and traumatic brain injury.

PsychoGenics' capabilities include behavioral testing across multiple CNS indications with over 80 optimized and validated behavioral tests, specialized preclinical models of CNS diseases (genetic, pharmacological and surgical), and complementary services including:

- A variety of transgenic mouse and rat models including custom breeding in our facility, genotyping, and phenotyping
- Electrophysiology: in vivo single and multi-unit recordings and LTP, slice and in vitro (Dynaflow) recordings. Slice LTP and EEG coming soon
- Molecular and cell biology: qWestern, qPCR, ELISA, microwave technology to assess phosphoproteins and second messengers enrichment in vivo, receptor autoradiography, and in vivo/ex vivo receptor occupancy
- Neurochemistry and microdialysis with multiple analytes assessment in tissue (brain, skin, muscle), CSF, or blood

New service in 2012: Oncology (subcutaneous, intrasplenic and intrahepatic tumor xenograft models)

PsychoGenics’ proprietary technologies are developed to facilitate high throughput, in vivo, compound screening for determination of therapeutic indication, repurposing, lead optimization, safety margin and detailed phenotyping. PsychoGenics transforms drug discovery by combining expertise in behavioral neurobiology with the power of bioinformatics in conjunction with proprietary, high-throughput behavioral testing platforms that rapidly screen compound libraries for CNS activity. These platforms form the core of drug discovery partnerships with major pharmaceutical companies, including Eli Lilly, Roche and Sunovion.

The Highest Quality and Professional Standards
PsychoGenics is committed to excellence in quality at all levels and prides itself on its rigorous quality control procedures. Work is conducted in PsychoGenics' 65,000 sq. ft. AAALAC accredited facilities. No test is offered without extensive validation. Many tests have been validated in multiple strains of mice or rats, and have shown the desired response to standard reference compounds. Studies on client compounds include a standard reference compound where possible.

To learn more, contact us at info@psychogenics.com or visit us at www.psychogenics.com.


 Key Statistics


Email: info@psychogenics.com
Ownership: Private

Web Site: PsychoGenics Inc.
Employees:
Symbol: 
 









 Company News
PsychoGenics Inc. Achieves Substantial Milestone in Its Drug Discovery Collaboration With Sunovion Pharmaceuticals Inc. 11/5/2012 9:49:18 AM    More...
Afraxis, Inc. and PsychoGenics Inc. Form Alliance to Offer Afraxis’ ESP Technology for Drug Discovery 7/16/2012 10:36:22 AM    More...
Afraxis, Inc. and PsychoGenics Inc. Form Alliance to Offer Afraxis' ESP Technology for Drug Discovery 7/16/2012 10:20:26 AM    More...
PsychoGenics Inc. Announces Positive Efficacy Data in Levodopa Induced Dyskinesia in Parkinson's Patients 6/12/2012 10:12:59 AM    More...
PsychoGenics Inc. Expands its In Vivo Capabilities with the Addition of Preclinical Magnetic Resonance Imaging Technology Services in Partnership with Ekam Imaging 2/8/2012 7:19:38 AM    More...
PsychoGenics Inc. Offers Traumatic Brain Injury Model 1/30/2012 2:39:20 PM    More...
PsychoGenics Inc. Offers Multiple Huntington Disease Models 1/23/2012 9:59:24 AM    More...
PsychoGenics Inc. Offers Spinal Cord Injury Model 12/1/2011 9:38:00 AM    More...
PsychoGenics Inc. Achieves Milestone in its Discovery Collaboration with Roche (RHHBY) 11/16/2011 10:17:21 AM    More...
PsychoGenics Inc. Offers Mouse Models of Spinal Muscular Atrophy 8/12/2011 10:46:14 AM    More...
1234